阿莫西林/克拉维酸和替卡西林/克拉维酸的作用特点和临床应用
被引量：3
摘要
含克拉维酸复合制剂的开发是克服病原菌对β_内酰胺类抗生素耐药和提高感染性疾病抗菌疗法疗效的重要途径.
出处
《国外医药（抗生素分册）》
CAS
1998年第6期438-440,共3页
World Notes on Antibiotics
同被引文献25
-
1Cole.Process for production of clavulanic acid[P].United States Patent,4110165.1978-8-29.
-
2Higgens C E,Kastner R E.Streptomyces clavuligerus sp.A-lactam antibiotic producer[J].International Journal of Systematic Bacteriology,1971,21(4):326-330.
-
3Pitlik J,Townsend C A.The fate of[2,3,3-2h3,1,2-13C2],D,L-glycerate in clavulanic acid biosynthesis[J].Journal of the Chemical Society.Chemical Communica-tions,1997,32(2):225-234.
-
4Liras P,Rodriguez-Gracia A.Clavulanic acid,aβ-lacta-mase inhibitor:biosynthesis and molecular genetics[J].Applied Microbiology and Biotechnology,2000,54(4):467-475.
-
5Henikoff S,Haughn G W,Calvo J M,et al.A large family of bacterial activeator proteins[J].Proceedings of the Na-tional Academy of Sciences,1988,85(18):6602-6606.
-
6Butler M J,Davey C C,Krygmsan P,et al.Cloning of ge-netic loci involved in endoprotease activity in Streptomyces lividans66:a novel neutral protease gene with an adjacent divergent putative regulatory gene.[J].Canadian Journal of Microbiology,1992,38(9):912-920.
-
7H C Lynch,Y Yang.Degradation products of clavulanic acid promote clavulanic acid production in cultures of Streptomyces clavuligerus[J].Enzyme and Microbiology Technology,2004,34(1):48-54.
-
8Salowe S P,Marsh E N,Townsend CA.Purification and characterization of clavaminate synthase from Streptomyces clavuligetus:an unusual oxidative enzyme in natural prod-uct biosynthesis[J].Biochemistry,1990,29(27):6499-6508.
-
9Tobias K,Bibb M J,Mark J B,et al.Practical Strepto-myces genetic:A Laboratory Manual[M].2ed.Lon-don:John Innes Foundation Press,2000:311-334.
-
10Zuo Zhi-han,Wang Yan-ping.Application of lat gene disruptionto increase the clavulanic acid production of Streptomyces clavuligerus[J].Journal of Molecular Catal-ysis B:Enzymatic,2006,43(1-4):102-107.
引证文献3
-
1陈长贵,王午喜,朱爱冬,张融.阿莫西林/克拉维酸钾治疗呼吸道感染疗效比较[J].儿科药学杂志,2004,10(5):51-53. 被引量：1
-
2左志晗,赵海龙.claR基因的扩增对棒状链霉菌棒酸合成的影响[J].食品与发酵工业,2012,38(1):25-29.
-
3吴仕孝.安奇——一个值得介绍的抗菌药[J].儿科药学杂志,2003,9(6):50-51. 被引量：1
-
1郁和平.阿莫西林/克拉维酸和替卡西林/克拉维酸对人类粒性细胞活性的影响[J].国外医药（抗生素分册）,1998,19(2):96-99. 被引量：6
-
2刘广春,杨秉一.他唑巴坦／哌拉西林复合制剂的进展[J].中国医药情报,2000,6(3):5-8. 被引量：1
-
3任进民,王川平.阿莫西林与克拉维酸复合制剂临床药理研究进展[J].河北医科大学学报,1999,20(1):54-56. 被引量：11
-
4何解生,章静.阿莫西林/克拉维酸钾的临床应用[J].海峡药学,2006,18(2):136-136. 被引量：12
-
5杨晓庆.β-内酰胺酶抑制剂的复合制剂在抗菌谱、临床适应证及不良反应方面的区别[J].中国社区医师,2008,24(14):25-25.
-
6朱珠,宣大伟.人血清中替卡西林的改良离子对高压液相色谱法[J].中国药理学报,1996,17(5):395-398.
-
7孕妇用药早知道[J].中外健康文摘,2007(09B):31-31.
-
8马登扬,陈挺,蒋悦,吴晓芬,朱庆峰.哌拉西林/他唑巴坦治疗住院患者泌尿系统感染的疗效分析[J].中华医院感染学杂志,2013,23(7):1684-1685. 被引量：3
-
9叶青.柱晶白霉素的抗菌活性[J].黑龙江医药,1998,11(1):36-36.
-
10张姝.幼儿选用止咳糖浆[J].健康伴侣,2012(10):53-53.
